Jennifer Johnson
Centennial Medical Center · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Thomas Jefferson University Hospitial
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
9
all conditions, ClinicalTrials.gov
NIH grants tied to them
10
11 more share only the name and are not shown
Trial papers
993
PubMed author-name match
Trials
Studies that name Jennifer Johnson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:18 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05069428 · Delirium Reduction With RamelteonCentennial Medical Center · unknown · Delirium · principal investigator
- N/ANCT04028479 · The Registry of Oncology Outcomes Associated With Testing and TreatmentTaproot Health · completed · Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer · principal investigator
- Ph2NCT03342911 · Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by SurgerySidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Name Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage II Oropharyngeal Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma · principal investigator
- Early Ph1NCT03162731 · Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck CancerSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Larynx, Lip, Oral Cavity and Pharynx · principal investigator
- Ph2NCT03076281 · Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell CarcinomaSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · Larynx, LIP, Oral Cavity · principal investigator
- Ph1NCT02960594 · hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of RelapseInovio Pharmaceuticals · completed · Breast Cancer, Lung Cancer, Pancreatic Cancer · principal investigator
- Ph2NCT02874430 · Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine CancerSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma · principal investigator
- N/ANCT02759172 · Suicide Prevention Intervention for At-Risk Individuals in TransitionMichigan State University · completed · Suicide · principal investigator
- Ph1NCT02318771 · Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung CancerSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Head and Neck Squamous Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Head and Neck Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 11 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Multilevel Interventions for Maternal Health and Disparities (MIRACLE) Center U54HD113291 · NICHD · HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES · fiscal years 2023 to 2026 · $3,326,546 awarded in 2026Same name and institution; not confirmed by an ID
- Sidney Kimmel Cancer Center LAPS Institutional CollaborationUG1CA233341 · NCI · THOMAS JEFFERSON UNIVERSITY · fiscal years 2023 to 2026 · $544,790 awarded in 2026Same name and institution; not confirmed by an ID
- The National Center for Health and Criminal-Legal Systems Integration for Suicide PreventionP50MH127512 · NIMH · MICHIGAN STATE UNIVERSITY · fiscal years 2022 to 2026 · $2,911,839 awarded in 2026Same name and institution; not confirmed by an ID
- The ROSE Scale-Up Study: Informing a decision about ROSE as universal postpartum depression preventionR01MH130948 · NIMH · MICHIGAN STATE UNIVERSITY · fiscal years 2022 to 2026 · $1,249,953 awarded in 2026Same name and institution; not confirmed by an ID
- IPT for major depression following perinatal lossR01HD100471 · NICHD · MICHIGAN STATE UNIVERSITY · fiscal years 2020 to 2024 · $623,828 awarded in 2024Same name and institution; not confirmed by an ID
- Meeting women where they are: Multilevel intervention addressing racial disparities in maternal morbidity and mortalityR01MD016003 · NIMHD · MICHIGAN STATE UNIVERSITY · fiscal years 2020 to 2024 · $746,296 awarded in 2024Same name and institution; not confirmed by an ID
- Implementing to sustain: Determining the minimum necessary intervention to maintain a postpartum depression prevention program (ROSE) in clinics providing prenatal services to low-income womenR01MH114883 · NIMH · MICHIGAN STATE UNIVERSITY · fiscal years 2018 to 2022 · $678,154 awarded in 2022Same name and institution; not confirmed by an ID
- Dissemination and Implementation Science CoreU54MD011227 · NIMHD · MICHIGAN STATE UNIVERSITY · fiscal years 2017 to 2020 · $417,308 awarded in 2020Same name and institution; not confirmed by an ID
- Suicide risk reduction in the year following jail release: the SPIRIT Trial (Suicide Prevention Intervention for at-Risk Individuals in Transition)U01MH106660 · NIMH · MICHIGAN STATE UNIVERSITY · fiscal years 2015 to 2018 · $1,350,083 awarded in 2018Same name and institution; not confirmed by an ID
- Effects of prisoner re-entry context on cognitive ability to manage mental health at re-entryR21MH105626 · NIMH · MICHIGAN STATE UNIVERSITY · fiscal years 2015 to 2016 · $198,102 awarded in 2016Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:18 UTC. The ranking covers the 200 most relevant of 993 PubMed records, and a shared surname and initials can bring in a namesake. All 993 on PubMed
- Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.N Engl J Med · 20122,171 citationsRCR 69.0
- Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.N Engl J Med · 20121,665 citationsRCR 60.7
- Fractional flow reserve-guided PCI for stable coronary artery disease.N Engl J Med · 2014884 citationsRCR 29.4
- A pharmacogenetic versus a clinical algorithm for warfarin dosing.N Engl J Med · 2013604 citationsRCR 19.3
- 473 citationsRCR 26.0
- A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis.N Engl J Med · 2020452 citationsRCR 34.3
- 421 citationsRCR 30.8
- 373 citationsRCR 14.0
- FDA drug approval summary: erlotinib (Tarceva) tablets.Oncologist · 2005356 citationsRCR 7.1
- 292 citationsRCR 26.0